Shares of Cipla jumped 8% on Thursday as a clutch of brokerages issued bullish calls for the stock even after the pharma major reported a 55% year-on-year (YoY) decline in its consolidated net profit at Rs 555 crore in the fourth quarter.
The profit was compared with Rs 1,222 crore recorded in the last year's fourth quarter.The stock has rallied nearly 11% in the two sessions since the results were announced during market hours on Wednesday, hitting an intraday high of Rs 1,432.10 on Thursday morning.The company's revenue from operations slipped around 3% YoY to Rs 6,541 crore in the March quarter.EBITDA fell 35% to Rs 997 crore from Rs 1,538 crore in the year-ago period, while EBITDA margin contracted sharply to 15.2% from 22.8%.
For the entire financial year which ended on March 31, 2026, Cipla reported a 2% YoY rise in revenue to Rs 28,163 crore but 26% YoY decline in net profit to Rs 3,879 crore.Along with the Q4 results, Cipla announced that its board of directors, during their meeting have recommended a final dividend of Rs 13 per share for FY26.
The record date to determine the eligibility of shareholders set to receive the final dividend has been fixed on June 5.Nuvama on CiplaNuvama upgraded its rating on Cipla shares to ‘Buy’ from ‘Reduce’, and raised its target price to Rs 1,550 apiece.
